SEARCH

SEARCH BY CITATION

Additional Supporting Information may be found in the online version of this article.

FilenameFormatSizeDescription
hep26436-sup-0001-suppfig1A.tif86KSupporting Figure 1A Relationship between HBsAg levels and declines at week 12 (A and B) and at week 24 (C and D) and response to peginterferon therapy.
hep26436-sup-0002-suppfig1B.tif76KSupporting Figure 1B Relationship between HBsAg levels and declines at week 12 (A and B) and at week 24 (C and D) and response to peginterferon therapy.
hep26436-sup-0003-suppfig1C.tif88KSupporting Figure 1C Relationship between HBsAg levels and declines at week 12 (A and B) and at week 24 (C and D) and response to peginterferon therapy.
hep26436-sup-0004-suppfig1D.tif74KSupporting Figure 1D Relationship between HBsAg levels and declines at week 12 (A and B) and at week 24 (C and D) and response to peginterferon therapy.
hep26436-sup-0005-supptab1.doc27KSupporting Table 1: Characteristics of the study cohort by assigned therapy regimen

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.